Blog
RSS FeedPosted by Michael Wonder on 23 Oct 2017
Cheaper health plans promoted by Trump have a history of fraud
21 October 2017 - In signing a recent executive order, President Trump promised that millions of Americans could soon obtain ...
Posted by Michael Wonder on 22 Oct 2017
Will the FDA add suffixes to approved biologics' names?
20 October 2017 - Back in January, the US FDA finalised guidance on how biosimilars and their biologic reference products' ...
Posted by Michael Wonder on 21 Oct 2017
Janssen receives two U.S. FDA approvals for Simponi Aria (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis
20 October 2017 - Simponi Aria is the only fully-human anti-TNF-alpha infused therapy now approved for psoriatic arthritis, ankylosing spondylitis ...
Posted by Michael Wonder on 21 Oct 2017
Shingrix approved in the US for prevention of shingles in adults aged 50 and over
20 October 2017 - Pooled clinical trial results showed > 90 percent efficacy across all age groups. ...
Posted by Michael Wonder on 21 Oct 2017
FDA releases flurry of new, revised drug-specific guidance documents
19 October 2017 - The US FDA on Thursday released new draft guidances for 32 drugs, including for those companies ...
Posted by Michael Wonder on 21 Oct 2017
Rising cancer drug costs in the USA
20 October 2017 - The price of patented cancer drugs in the USA rises steadily after their launch, according to a ...
Posted by Michael Wonder on 21 Oct 2017
US payers struggle to keep up with high rate of FDA drug approvals
20 October 2017 - FDA incentives to encourage development of rare disease therapies have paid dividends, with an unprecedented number ...
Posted by Michael Wonder on 20 Oct 2017
Antares Pharma receives complete response letter from the FDA for Xyosted
20 October 2017 - Antares Pharma announced that today it has received a complete response letter from the U.S. FDA ...
Posted by Michael Wonder on 19 Oct 2017
Payers need access to pre-approval drug information
19 October 2017 - Healthcare payment in the United States is shifting toward value—a transformation that will require new approaches ...
Posted by Michael Wonder on 19 Oct 2017
Breast cancer: BRCA study sent to Canada because U.S. thinks women can't handle genetic test results
19 October 2017 - Hundreds of spit samples have been traveling through the mail across the U.S.-Canadian border. Why? The ...
Posted by Michael Wonder on 19 Oct 2017
Trump appears to back further away from bipartisan health care push
18 October 2017 - President Trump became the subject of an unusual public lobbying campaign over the fate of the ...
Posted by Michael Wonder on 19 Oct 2017
Health insurer Anthem takes pharmacy business in house, taps CVS to help
18 October 2017 - Anthem says it will start managing its billions of dollars of patient prescriptions itself in 2020, ending ...
Posted by Michael Wonder on 19 Oct 2017
Teva announces submission of biologics license application for fremanezumab to the U.S. FDA
17 October 2017 - Key milestone reached for Teva to advance global fremanezumab program for the preventive treatment of migraine. ...
Posted by Michael Wonder on 19 Oct 2017
FDA approves another amazing and costly cancer-killing gene therapy
18 October 2017 - In 2010, Josh Feldman was on his honeymoon -- a globe-spanning trip that at one point ...
Posted by Michael Wonder on 19 Oct 2017
Lessons from the latest ACA battle
18 October 2017 - At the end of the 2017 Obamacare repeal-and-replace legislative battle (and before the next one begins), ...